Back to Treatments

Treatment

BPaL Regimen (Bedaquiline, Pretomanid, Linezolid)

1
Conditions
15
Trials
1,500
Participants
58%
Average Safety

Condition Evidence

HIV/AIDS - Multidrug-resistant Tuberculosis without extensive drug resistance

15 trials · 1,500 participants

90% effectiveness · 58% safety
BPaL Regimen (Bedaquiline, Pretomanid, Linezolid) | DFDA